MicroRNA-99b-5p downregulates protein synthesis in human primary myotubes

Am J Physiol Cell Physiol. 2020 Aug 1;319(2):C432-C440. doi: 10.1152/ajpcell.00172.2020. Epub 2020 Jul 1.

Abstract

microRNAs (miRNAs) are important regulators of cellular homeostasis and exert their effect by directly controlling protein expression. We have previously reported an age-dependent negative association between microRNA-99b (miR-99b-5p) expression and muscle protein synthesis in human muscle in vivo. Here we investigated the role of miR-99b-5p as a potential negative regulator of protein synthesis via inhibition of mammalian target for rapamycin (MTOR) signaling in human primary myocytes. Overexpressing miR-99b-5p in human primary myotubes from young and old subjects significantly decreased protein synthesis with no effect of donor age. A binding interaction between miR-99b-5p and its putative binding site within the MTOR 3'-untranslated region (UTR) was confirmed in C2C12 myoblasts. The observed decline in protein synthesis was, however, not associated with a suppression of the MTOR protein but of its regulatory associated protein of mTOR complex 1 (RPTOR). These results demonstrate that modulating the expression levels of a miRNA can regulate protein synthesis in human muscle cells and provide a potential mechanism for muscle wasting in vivo.

Keywords: microRNA; muscle; primary muscle cells; protein synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions / genetics
  • Animals
  • Cell Proliferation / genetics
  • Gene Expression Regulation / genetics
  • Humans
  • Mechanistic Target of Rapamycin Complex 1 / genetics
  • Mice
  • MicroRNAs / genetics*
  • Muscle Fibers, Skeletal / metabolism*
  • Myoblasts / metabolism
  • Protein Biosynthesis / genetics*
  • Signal Transduction / genetics
  • TOR Serine-Threonine Kinases / genetics*

Substances

  • 3' Untranslated Regions
  • MIRN99 microRNA, human
  • MicroRNAs
  • MTOR protein, human
  • Mechanistic Target of Rapamycin Complex 1
  • TOR Serine-Threonine Kinases